CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 27th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2009, at 8:30 a.m. PT (11:30 a.m. ET) at The Westin St. Francis in San Francisco. This presentation will include a review of the company’s 2008 goals and the key scientific, product, and business goals for 2009.
